Metabolic heterogeneity signature of primary treatment-naïve prostate cancer

To avoid over- or under-treatment of primary prostate tumours, there is a critical need for molecular signatures to discriminate indolent from aggressive, lethal disease. Reprogrammed energy metabolism is an important hallmark of cancer, and abnormal metabolic characteristics of cancers have been im...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Dong, Ettinger, Susan L., Qu, Sifeng, Xue, Hui, Nabavi, Noushin, Chuen Choi, Stephen Yiu, Bell, Robert H., Mo, Fan, Haegert, Anne M., Gout, Peter W., Fleshner, Neil, Gleave, Martin E., Pollak, Michael, Collins, Colin C., Wang, Yuzhuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5432227/
https://www.ncbi.nlm.nih.gov/pubmed/28460430
http://dx.doi.org/10.18632/oncotarget.15237

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5432227/
https://www.ncbi.nlm.nih.gov/pubmed/28460430
http://dx.doi.org/10.18632/oncotarget.15237

Ejemplares similares